Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debora Soncini

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Human Immunology|February 19, 2026
The immunosuppressive role of HLA-G<sup>+</sup> extracellular vesicles in bone marrow of infiltrating tumors: The lesson learned from neuroblastoma and multiple myelomaIrma Airoldi, Debora Soncini, Danilo Marimpietri, et al.
Cancers|May 27, 2026
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future PerspectivesMatteo Garibotto, Debora Soncini, Roberto Massimo Lemoli, et al.
International Journal of Cancer|October 31, 2009
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalphaEnrica Balza, Barbara Carnemolla, Lorenzo Mortara, et al.
Blood Advances|June 9, 2026
CRISPR application in hematological disorders: from bench to bedsideFrancesco Ladisa, Eugenio Morelli, Debora Soncini, et al.
Frontiers in Immunology|September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Current Drug Targets|March 28, 2013
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experienceFabrizio Montecucco, Michele Cea, Inga Bauer, et al.
The Journal of Biological Chemistry|July 25, 2013
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cellsAlessia Grozio, Giovanna Sociali, Laura Sturla, et al.
Plos One|February 4, 2010
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repressionAlessio Nencioni, Michele Cea, Anna Garuti, et al.
Oncotarget|April 25, 2015
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibitionIrene Caffa, Vito D'Agostino, Patrizia Damonte, et al.
Clinical and Experimental Medicine|April 15, 2025
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategiesPasquale Esposito, Lucia Macciò, Antonia Cagnetta, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Human Immunology|February 19, 2026
The immunosuppressive role of HLA-G<sup>+</sup> extracellular vesicles in bone marrow of infiltrating tumors: The lesson learned from neuroblastoma and multiple myelomaIrma Airoldi, Debora Soncini, Danilo Marimpietri, et al.
Cancers|May 27, 2026
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future PerspectivesMatteo Garibotto, Debora Soncini, Roberto Massimo Lemoli, et al.
International Journal of Cancer|October 31, 2009
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalphaEnrica Balza, Barbara Carnemolla, Lorenzo Mortara, et al.
Blood Advances|June 9, 2026
CRISPR application in hematological disorders: from bench to bedsideFrancesco Ladisa, Eugenio Morelli, Debora Soncini, et al.
Frontiers in Immunology|September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Current Drug Targets|March 28, 2013
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experienceFabrizio Montecucco, Michele Cea, Inga Bauer, et al.
The Journal of Biological Chemistry|July 25, 2013
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cellsAlessia Grozio, Giovanna Sociali, Laura Sturla, et al.
Plos One|February 4, 2010
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repressionAlessio Nencioni, Michele Cea, Anna Garuti, et al.
Oncotarget|April 25, 2015
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibitionIrene Caffa, Vito D'Agostino, Patrizia Damonte, et al.
Clinical and Experimental Medicine|April 15, 2025
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategiesPasquale Esposito, Lucia Macciò, Antonia Cagnetta, et al.
Pageof 4